Lunch brief: Navigating wellness across a lifetime: From omega-3 solutions to stage-specific body chemistry (Bonerge)

Presentation 1

Omega-3 as a solution to global health problems

Omega-3 deficiencies are a critical public health issue. Jing Xuan Kang, principal investigator and director of the Laboratory for Lipid Medicine and Technology at Massachusetts General Hospital, will explore new scientific and technological advances to create scalable solutions and a roadmap for global integration.

Join us to learn how you can help bridge the gap between omega-3 science and positive public health impact.

4 takeaways:

1. The scale of omega-3 deficiency as a health risk.
2. Innovations in biomarkers and fortified foods.
3. A practical roadmap for implementation.
4. How different sectors can collaborate.

Speaker:

• Jing Xuan Kang, principal investigator and director of the Laboratory for Lipid Medicine and Technology, Massachusetts General Hospital

Presentation 2

Life stages and& phases: Body chemistry

A father-daughter duo’s perspective on gender-specific biochemical changes

This presentation explores how body chemistry evolves across life stages in both men and women, highlighting critical biochemical transitions that create opportunities for targeted nutraceutical interventions. While the nutraceutical industry has mastered vitamins and minerals, we're just beginning to understand how hormonal and metabolic chemistry shifts throughout life to create unique health vulnerabilities and opportunities.

4 Four takeaways:

1. Body chemistry shifts significantly throughout life.
2. These transitions create unique health vulnerabilities.
3. They also present new opportunities for intervention.
4. Targeted nutraceuticals can address these specific, changing needs.

Speakers:

• Anand Swaroop, Ph.D., FACN, Founder, Cepham Inc.
• Ananya Swaroop, Ph.D., Clinical scientist, Cepham Inc.

Moderator:

• Traci Kantowski, VP of Global Communications and Business Development, Cypress Minerals

If you are interested in attending, please sign-up here!